Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence
Reissue Patent
2006-10-17
2006-10-17
Allen, Marianne P. (Department: 1631)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
25 or more amino acid residues in defined sequence
C530S350000, C530S399000, C435S069700
Reissue Patent
active
RE039355
ABSTRACT:
Human insulin-like growth factor is synthesized in recombinant cell culture by host cells transformed with expression vectors bearing DNA encoding human insulin-like growth factor.
REFERENCES:
patent: 3953418 (1976-04-01), Yanaihara et al.
patent: 4110322 (1978-08-01), Greven et al.
patent: 4342832 (1982-08-01), Goeddel et al.
patent: 4350764 (1982-09-01), Baxter et al.
patent: 4366246 (1982-12-01), Riggs
patent: 4387162 (1983-06-01), Aigle et al.
patent: 4411994 (1983-10-01), Gilbert et al.
patent: 4425437 (1984-01-01), Riggs
patent: 4431740 (1984-02-01), Bell et al.
patent: 4440859 (1984-04-01), Rutter et al.
patent: 4530904 (1985-07-01), Hershberger et al.
patent: 4543329 (1985-09-01), Daum et al.
patent: 4546082 (1985-10-01), Kurjan et al.
patent: 4588684 (1986-05-01), Brake
patent: 4652525 (1987-03-01), Rutter et al.
patent: 4658021 (1987-04-01), Goeddel et al.
patent: 4745179 (1988-05-01), Ueda et al.
patent: 5015575 (1991-05-01), Brake et al.
patent: 1214739 (1986-12-01), None
patent: 022242 (1979-07-01), None
patent: 026598 (1981-04-01), None
patent: 046039 (1982-02-01), None
patent: 055945 (1982-07-01), None
patent: 075444 (1983-03-01), None
patent: 116201 (1984-08-01), None
patent: 121352 (1984-10-01), None
patent: 123228 (1984-10-01), None
patent: 123289 (1984-10-01), None
patent: 123294 (1984-10-01), None
patent: 123544 (1984-10-01), None
patent: 130166 (1985-01-01), None
patent: 135094 (1985-03-01), None
patent: 155655 (1985-09-01), None
patent: 189481 (1986-08-01), None
patent: 56-95199 (1981-08-01), None
patent: 57-200343 (1982-12-01), None
patent: 8302324 (1985-01-01), None
patent: WO 84/03103 (1984-08-01), None
“Chiron's elegant, general purpose, rDNA yeast system. A breakthrough?”Biotech News3(10):1-3 (May 15, 1983).
“Har “byggdes” Sveriges forsta konstgjorda gen”Svdsvenska Dagbladet(Feb. 1, 1983).
“Konstgjort arvsanlag framstallt vid Kabi”Goteborgs-Posten(Feb. 3, 1983).
Achstetter and Wolf, “Hormone processing and membrane-bound proteinases in yeast”The EMBO Journal4(1):173-177 (1985).
Alberts, B.Molecular Biology of the Cell,New York and London:Garland Publishing, Inc. pps. 215 (1983).
Astell et al, “The sequence of DNAs coding for the mating type loci ofsaccharomyces cerevisiae” Cell27:15-23 (1981).
Baum, R.M., “Enzyme chemistry set to advance as new techniques are applied”Chemical and Engineering Newspps. 7-14 (Jul. 14, 1986).
Bell et al., “Nucleotide sequence of a cDNA clone encoding human preproinsulin”Nature282:525-527 (1979).
Bell et al., “Sequence of a cDNA clone encoding human preproinsulin-like growth factor II”Nature310:775-777 (1984).
Bradshaw and Niall, “Insulin-related growth factors”TIBS3:274-278 (1978).
Brake et al, “α-Factor-directed synthesis and secretion of mature foreign proteins inSaccharomyces cerevisiae” Proc. Natl. Acad. Sci81:4642-4646 (1984).
Brake et al., “Identification and Characterization of a Structural Gene for the Yeast Peptide Mating Pheromone, a-factor”J. Cell. Biochem.(abstract 1497) Supp. 7B (Apr. 29, 1983).
Brousseau et al., “Synthesis of a human insulin gene V. Enzymatic assembly, cloning and characterization of the human proinsulin DNA”Gene17:279-289 (1982).
Carpenter, “Epidermal growth factor is a major growth-promoting agent in human milk”Chemical Abstracts(abstract No. 215932m) 93:96 (1980).
Carpenter and Cohen, “Chapter 5—Epidermal Growth Factors”Biochemical Actions of Hormones(summarized in Chemical Abstracts, vol. 91 (11) 83626m (1979)), Academic Press, Inc. vol. V:203-247 (1978).
Carpenter et al., “Characterization of the binding of I-labeled epidermal growth factor to human fibroblasts”J. Biol. Chemistry250(11):4297-4304 (Jun. 10, 1975).
Casabadan, “Transposition and Fusion of the lac Genes to Selected Promoters inEscherichia coliusing Bacteriophage Lambda and Mu”J. Mol. Biol.104:541-555 (1976).
Catanzaro et al., “Immunoscreening of Expression Clones Using Antibodies to Renin, EGF and NGF”Manipulation and Expression of Genes in Eukaryotes,Nagley et al. pps. 11-12 (1983).
Chan et al., “Cell-free synthesis of rat preproinsulins: Characterization and partial amino acid sequence determination”Proc. Natl. Acad. Sci. USA73(6):1964-1968 (1976).
City of Hope; Genentech, Inc., “Research Scientists Synthesize Genes to “Command” Laboratory Bacteria to Manufacture Human Insulin”Press Release(Sep. 6, 1978).
Crea et al., “Chemical synthesis of genes for human insulin”0Proc. Natl. Acad. Sci. USA75:5765-5769 (1978).
Davis and Tai, “The mechanism of protein secretion across membranes”Nature283:433-438 (1980).
Dayhoff, “Table of Contents, Preface, Data Section, Protein Data Introduction, Hormones, Active Peptides and Toxins”Atlas of Protein Sequence and Structure,Silver Spring: The National Biomedical Research Foundation vol. 5:vii-xxx, D1-D6, D176, D177, D2 (1972).
Dayhoff, “Table of Contents, Preface, Protein Data Introduction, Hormones and Active Peptides”Atlas of Protein Sequence and Structure,Silver Spring:The National Biomedical Research Foundation vol. 5(Supp. 3):vii-xxii, 25-28, 145-164 (1978).
Dayhoff, “Table of Contents, Preface, Protein Data Introduction, Hormones and Active Peptides”Atlas of Protein Sequence and Structure,Washington, DC:National Biomedical Research Foundation vol. 5(Supp. 2):vii-xx, 14, 21-24, 113-145 (1976).
deHaen et al., “Characterization of Proinsulin-Insulin Intermediates in Human Plasma”J. Clin. Invest.62:727-737 (1978).
Dicker et al., “Similarities between fibroblast-derived growth factor and platelet-derived growth factor”Chemical Abstracts(abstract No. 201393r) 95:454 (1981).
Docherty et al., “Post-translational proteolysis in polypeptide hormone biosynthesis”Annu Rev Physiol44:625-638 (1982).
Edge et al., “Total Synthesis of a Human Leukocyte Interferon Gene”Nature292:756-762 (1981).
Estell et al., “Engineering an enzyme by site-directed mutagenesis to be resistant to chemical oxidation”J. Biol. Chemistry260(11):6518-6521 (1985).
Frank and Chance, “Two Routes for Producing Human Insulin Utilizing Recombinant DNA Technology”Munch. med. Wschr.125:14-20 (1983).
Gait, “Synthetic genes for human insulin”Nature277:429-430 (1979).
Genentech, Inc., “First Successful Laboratory Production of Human Insulin Announced”Press Release(Sep. 6, 1978).
Gill et al.Recombinant DNA,Walton, A.G. pps. 213-227 (1981).
Goeddel et al., “Expression inEscherichia coliof Chemically Synthesized Genes for Human Insulin”Proc. Natl. Acad. Sci. USA76(1):106-110 (1979).
Gregory, H., “Isolation and structure of urogastrone and its relationship to epidermal growth factor”Nature257:325-327 (Sep. 25, 1975).
Grosjean and Fiers, “Preferential codon usage in prokaryotic genes: the optimal codon-anticodon interaction energy and the selective codon usage in efficiently expressed genes”Gene18:199-209 (1982).
Higuchi et al., “A general method for cloning eukaryotic structural gene sequences”Proc. Natl. Acad. Sci. USA73(9):3146-3150 (1976).
Hinnen et al., “High expression and secretion of foreign proteins in yeast”Chemical Abstracts(abstract No. 40931k) 102:150 (1985).
Hitzeman et al., “Expression of a Human Gene for Interferon in Yeast”Nature293:717-722 (1981).
Hitzeman et al., “Secretion of human interferons by yeast”Science219:620-625 (1983).
Hsiung et al., “Synthesis of human insulin gene. Part I. Development of reversed-phase chromatography in the modified triester method. Its application in the rapid and efficient synthesis of eight deoxyriboligonucleotides fragments constituting human insulin A DNA”Nucl. Acids Res.6:1371-1385 (1979).
Hsiu
Lee James M.
Ullrich Axel
Allen Marianne P.
Dreger Ginger R.
Genetech, Inc.
Hasak Janet E.
Heller Ehrman LLP
LandOfFree
Preparation of human IGF via recombinant DNA technology does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation of human IGF via recombinant DNA technology, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of human IGF via recombinant DNA technology will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3642957